Acarix’ reported net sales in line with our expectations, with a slightly higher EBIT than forecasted due to lower OPEX in the quarter. More importantly, Acarix is continuing its expansion in Europe and progressing in clinical trials with the CADScor system.

info@redeye.se (Redeye.se)

Redeye AB - Redeye.se